Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 3
2006 3
2007 5
2008 2
2009 2
2010 3
2011 4
2012 6
2013 5
2014 5
2015 12
2016 1
2017 2
2018 4
2019 6
2020 5
2021 9
2022 9
2023 8
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. Bergamaschi MM, et al. Among authors: hallak je. Neuropsychopharmacology. 2011 May;36(6):1219-26. doi: 10.1038/npp.2011.6. Epub 2011 Feb 9. Neuropsychopharmacology. 2011. PMID: 21307846 Free PMC article. Clinical Trial.
Cognition in at-risk mental states for psychosis.
de Paula AL, Hallak JE, Maia-de-Oliveira JP, Bressan RA, Machado-de-Sousa JP. de Paula AL, et al. Among authors: hallak je. Neurosci Biobehav Rev. 2015 Oct;57:199-208. doi: 10.1016/j.neubiorev.2015.09.006. Epub 2015 Sep 10. Neurosci Biobehav Rev. 2015. PMID: 26365107 Review.
An Overview on the Search for Schizophrenia Biomarkers.
Hallak JE, de Paula AL, Chaves C, Bressan RA, Machado-de-Sousa JP. Hallak JE, et al. CNS Neurol Disord Drug Targets. 2015;14(8):996-1000. doi: 10.2174/1871527314666150909114957. CNS Neurol Disord Drug Targets. 2015. PMID: 26350336 Review.
The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A Post Hoc Exploratory Analysis of Phase 2/3 Clinical Trial.
de Almeida CMO, Brito MMC, Bosaipo NB, Pimentel AV, Sobreira-Neto MA, Tumas V, Zuardi AW, Crippa JAS, Hallak JEC, Eckeli AL. de Almeida CMO, et al. Among authors: hallak jec. Cannabis Cannabinoid Res. 2023 Apr;8(2):374-378. doi: 10.1089/can.2021.0158. Epub 2022 Jun 24. Cannabis Cannabinoid Res. 2023. PMID: 35749710 Clinical Trial.
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug.
Schier AR, Ribeiro NP, Silva AC, Hallak JE, Crippa JA, Nardi AE, Zuardi AW. Schier AR, et al. Among authors: hallak je. Braz J Psychiatry. 2012 Jun;34 Suppl 1:S104-10. doi: 10.1590/s1516-44462012000500008. Braz J Psychiatry. 2012. PMID: 22729452 Free article. Review. English, Portuguese.
Pathophysiology of Major Depression by Clinical Stages.
de Menezes Galvão AC, Almeida RN, de Sousa GM Jr, Leocadio-Miguel MA, Palhano-Fontes F, de Araujo DB, Lobão-Soares B, Maia-de-Oliveira JP, Nunes EA, Hallak JEC, Schuch FB, Sarris J, Galvão-Coelho NL. de Menezes Galvão AC, et al. Among authors: hallak jec. Front Psychol. 2021 Aug 5;12:641779. doi: 10.3389/fpsyg.2021.641779. eCollection 2021. Front Psychol. 2021. PMID: 34421705 Free PMC article.
85 results